ATYR Q4 2020 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$89M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+1325.7% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$5M-240.6% margin

Net Income

-$5M-240.2% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+1287.2%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$340,000

Balance Sheet

Total Assets

$39M

Total Liabilities

$7M

Stockholders' Equity

$32M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$144,000	+1325.7%
Gross Profit	$2M	$144,000	+1325.7%
Operating Income	-$5M	-$6M	+17.1%
Net Income	-$5M	-$6M	+17.4%